Valanbio Therapeutics Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $421K
Latest Deal Amount

Valanbio Therapeutics General Information

Description

Developer of anti-infective drugs created to cure various bacterial diseases. The company is currently operating in stealth mode.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Delivery
Primary Office
  • 1120 Longstone Way
  • Raleigh, NC 27614
  • United States
+1 (919) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Valanbio Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 14-Jan-2020 $421K 00000 Completed Stealth
To view Valanbio Therapeutics’s complete valuation and funding history, request access »

Valanbio Therapeutics Executive Team (3)

Name Title Board Seat Contact Info
Clayton Duncan Chief Executive Officer & Board Member
Moise Khayrallah Executive Officer & Board Member
Pei Zhou Executive Officer & Board Member
To view Valanbio Therapeutics’s complete executive team members history, request access »

Valanbio Therapeutics Board Members (5)

Name Representing Role Since
Clayton Duncan Valanbio Therapeutics Chief Executive Officer & Board Member 000 0000
Eric Toone Valanbio Therapeutics Board Member 000 0000
Moise Khayrallah Valanbio Therapeutics Executive Officer & Board Member 000 0000
Pei Zhou Valanbio Therapeutics Executive Officer & Board Member 000 0000
Sam Hopkins Valanbio Therapeutics Board Member 000 0000
To view Valanbio Therapeutics’s complete board members history, request access »